Le Lézard
Classified in: Health, Science and technology
Subjects: NPT, FVT

2024 Annual Meeting of the American College of Clinical Pharmacology® - The Premier Clinical Pharmacology Educational & Scientific Meeting


"Transformative Solutions: Delivering on the Promise of Clinical Pharmacology for Patient Care" 

ASHBURN, Va. , April 23, 2024 /PRNewswire/ -- The American College of Clinical Pharmacology® (ACCP) is pleased to announce its 2024 ACCP Annual Meeting (#2024ACCP) will be held September 8 ? 10, 2024. We encourage you to join us for this transformative educational and scientific event! ACCP provides healthcare professionals and scientists with a forum to exchange knowledge and ideas that promote and expand the value of clinical pharmacology in healthcare and drug development.

Early Bird registration ends June 30, 2024, reserve your seat today.

Dr. Dionna J. Green, President, ACCP stated, "I am pleased to formally invite you to the 2024ACCP Annual Meeting in Bethesda, MD! Come join this exceptional forum for an opportunity to build your professional network, reconnect with colleagues, and engage in a forward-looking and innovation-focused meeting program that will offer an array of exceptional scientific programming that provide insights into harnessing the power of clinical pharmacology in patient care."

The 3-day meeting includes:

ACCP is accredited by the Accreditation Council for Continuing Medical Education (ACCME) and the Accreditation Council for Pharmacy Education (ACPE) and offers CME & CPE Credits at no additional cost to Attendees.

About ACCP
ACCP is a non-profit association providing accredited Continuing Education, publications and career-enhancing opportunities to clinical pharmacology healthcare professionals.

SOURCE American College of Clinical Pharmacology


These press releases may also interest you

at 19:01
Butterfly Medical Welcomes Experienced Urology Executive to its Helm
Butterfly Medical Ltd, an early-stage medical device company focused on alleviating suffering in patients with BPH (Benign Prostatic Hyperplasia), is excited to announce the hiring of Patrick MacCarthy as CEO. ...

at 18:33
BioVaxys Technology Corp. Closes First Tranche of Private Placement
BioVaxys Technology Corp. (FRA: 5LB) (the "Company") is pleased to announce that it has closed the first tranche (the "First Tranche") of its previously announced non-brokered private placement (the "Private Placement") with the issuance of...

at 18:29
FILAMENT HEALTH ANNOUNCES CHANGE TO BOARD OF DIRECTORS
Filament Health Corp. (Cboe CA: FH) ("Filament" or the "Company"), a clinical-stage natural psychedelic drug development company, today announced that Chris Wagner has stepped down from his position as Director on the Company's board of directors...

at 18:20
National Institutes of Health All of Us Research Program Mobile Tour Visits Rochester, NY
Starting this week, National Alliance for Hispanic Health, Ibero American Action League Inc., University of Rochester Medical Center, and Trillium Health in Rochester, NY will host the All of Us Journey, a traveling educational exhibit that brings...

at 18:00
BetterLife Announces Intent to Complete Private Placement of Units
BetterLife Pharma Inc. ("BetterLife" or the "Company") , an emerging biotech company focused on the development and commercialization of non-hallucinogenic LSD-based therapeutics for mental disorders, today announced that the Company intends to...

at 17:48
ANDLAUER HEALTHCARE GROUP ANNOUNCES RESULTS OF VOTING AT ANNUAL MEETING OF SHAREHOLDERS
Andlauer Healthcare Group Inc. ("AHG" or the "Company") announced today the results of voting at its virtual annual meeting of shareholders held on May 3, 2024 (the "Meeting"). All of the nominees listed in the management information circular...

More news about Health...


News published on and distributed by: